AU2022386164A1 - Protein tyrosine phosphatase inhibitors and methods of use thereof - Google Patents
Protein tyrosine phosphatase inhibitors and methods of use thereof Download PDFInfo
- Publication number
- AU2022386164A1 AU2022386164A1 AU2022386164A AU2022386164A AU2022386164A1 AU 2022386164 A1 AU2022386164 A1 AU 2022386164A1 AU 2022386164 A AU2022386164 A AU 2022386164A AU 2022386164 A AU2022386164 A AU 2022386164A AU 2022386164 A1 AU2022386164 A1 AU 2022386164A1
- Authority
- AU
- Australia
- Prior art keywords
- hydroxy
- dihydro
- benzothiopyran
- fluoro
- trione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278336P | 2021-11-11 | 2021-11-11 | |
| US63/278,336 | 2021-11-11 | ||
| PCT/US2022/049581 WO2023086495A1 (en) | 2021-11-11 | 2022-11-10 | Protein tyrosine phosphatase inhibitors and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022386164A1 true AU2022386164A1 (en) | 2024-05-23 |
Family
ID=84887566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022386164A Pending AU2022386164A1 (en) | 2021-11-11 | 2022-11-10 | Protein tyrosine phosphatase inhibitors and methods of use thereof |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250042894A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4430039A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024543451A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118556055A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022386164A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3236853A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005656A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023086495A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024243441A1 (en) | 2023-05-24 | 2024-11-28 | Kumquat Biosciences Inc. | Heterocyclic compounds and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA94921C2 (en) * | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| TWI888352B (zh) * | 2018-06-21 | 2025-07-01 | 美商嘉來克生命科學有限責任公司 | 蛋白質酪胺酸磷酸酯酶抑制劑及其使用方法 |
| KR102983496B1 (ko) * | 2019-03-14 | 2026-06-29 | 칼리코 라이프 사이언시스 엘엘씨 | 단백질 티로신 포스파타제 억제제 및 이의 사용 방법 |
| MX2022007441A (es) * | 2019-12-18 | 2022-09-02 | Calico Life Sciences Llc | Inhibidores de proteína tirosina fosfatasa y sus métodos de uso. |
-
2022
- 2022-11-10 CN CN202280088452.2A patent/CN118556055A/zh active Pending
- 2022-11-10 WO PCT/US2022/049581 patent/WO2023086495A1/en not_active Ceased
- 2022-11-10 CA CA3236853A patent/CA3236853A1/en active Pending
- 2022-11-10 US US18/709,204 patent/US20250042894A1/en active Pending
- 2022-11-10 MX MX2024005656A patent/MX2024005656A/es unknown
- 2022-11-10 JP JP2024527749A patent/JP2024543451A/ja active Pending
- 2022-11-10 AU AU2022386164A patent/AU2022386164A1/en active Pending
- 2022-11-10 EP EP22839527.3A patent/EP4430039A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN118556055A (zh) | 2024-08-27 |
| JP2024543451A (ja) | 2024-11-21 |
| EP4430039A1 (en) | 2024-09-18 |
| CA3236853A1 (en) | 2023-05-19 |
| MX2024005656A (es) | 2024-08-06 |
| US20250042894A1 (en) | 2025-02-06 |
| WO2023086495A1 (en) | 2023-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12227484B2 (en) | Inhibitors of PARG | |
| EP3580224B1 (en) | Ask1 inhibiting agents | |
| WO2023201044A2 (en) | Jak inhibitor analogs, formulations, and uses thereof | |
| AU2023358081A1 (en) | Novel bicyclic heterocyclyl compounds and use thereof | |
| KR20210016344A (ko) | 신규한 화합물 | |
| US11236086B2 (en) | Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase | |
| EP3865474A1 (en) | Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use | |
| JP6807054B2 (ja) | 環状アミン誘導体及びその医薬用途 | |
| EP4107153A1 (en) | Compounds | |
| TW201204346A (en) | Novel hydroxamic acid derivative | |
| EA019488B1 (ru) | Ингибиторы limk2 и способы их применения | |
| BR112020013141A2 (pt) | óxi-fluoropiperidina como inibidor de quinase | |
| WO2021079196A2 (en) | Mettl3 modulators | |
| RS62271B1 (sr) | Inhibitori 3-fosfoglicerat dehidrogenaze i njihova upotreba | |
| US20250019374A1 (en) | Protein tyrosine phosphatase inhibitors and methods of use thereof | |
| EP3400226A1 (en) | Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancer | |
| CA3168222A1 (en) | Pyrrolopyrimidine derivatives and pharmaceutical composition for preventing or treating protein kinase-related disease comprising the same as an active ingredient | |
| US20240092761A1 (en) | Quinazoline compounds and methods of use | |
| WO2023086495A1 (en) | Protein tyrosine phosphatase inhibitors and methods of use thereof | |
| WO2011102404A1 (ja) | イミダゾール誘導体 | |
| EP4011865A1 (en) | Bridged heterocyclyl-substituted pyrimidine compound, preparation method therefor, and pharmaceutical use thereof | |
| WO2019022235A1 (ja) | 円形脱毛症の治療剤又は予防剤 | |
| TWI652265B (zh) | 氮雜吲哚衍生物 | |
| AU2020421654A1 (en) | RORγt inhibitor, preparation method thereof and use thereof | |
| CA3070717C (en) | Inhibitors of plasma kallikrein and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: CALICO LIFE SCIENCES LLC Free format text: FORMER APPLICANT(S): CALICO LIFE SCIENCES LLC; ABBVIE INC. |